Literature DB >> 7013276

Disorders of platelet function: mechanisms, diagnosis and management.

L B Huebsch, L A Harker.   

Abstract

Platelets play an important role in hemostasis, and alterations in platelet function may be the cause of abnormal bleeding in a wide variety of congenital and acquired clinical disorders. Platelet dysfunction may be classified as disorders of (1) substrate connective tissue, (2) adhesion, (3) aggregation and (4) platelet-release reaction. The congenital defects of platelet function, although uncommon, have provided important insights into platelet physiology and pathophysiology and, as a group, are less common, better characterized and more readily classified than the acquired defects. The severity of bleeding resulting from platelet dysfunction varies greatly and is substantially increased when another defect of hemostasis coexists. A disorder of platelet function is suspected on the basis of the history and physical examination and is confirmed by the finding of a prolonged bleeding time in the presence of an adequate number of platelets. A specific diagnosis often requires measurements of the factor VIII and von Willebrand factor complex and other tests of platelet function. Some of these tests may be available only in specialized laboratories. Therapy for bleeding episodes resulting from platelet dysfunction is directed at (1) removing or treating the underlying cause of the platelet disorder; (2) replacing the missing plasma cofactors needed to support normal platelet function (such as by the transfusion of cryoprecipitate in patients with von Willebrand disease, and (3) transfusing functional platelets in the form of platelet concentrates in patients with disorders of intrinsic platelet dysfunction.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7013276      PMCID: PMC1272531     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


  101 in total

1.  The bleeding disorder of uraemia. A qualitative platelet defect.

Authors:  P A Castaldi; M C Rozenberg; J H Stewart
Journal:  Lancet       Date:  1966-07-09       Impact factor: 79.321

2.  Pharmacologic control of thromboembolic complications of cardiac-valve replacement.

Authors:  J M Sullivan; D E Harken; R Gorlin
Journal:  N Engl J Med       Date:  1971-06-24       Impact factor: 91.245

3.  Gray platelet syndrome. A variety of qualitative platelet disorder.

Authors:  G Raccuglia
Journal:  Am J Med       Date:  1971-12       Impact factor: 4.965

4.  Further studies on the platelet-inhibitory effect of guanidinosuccinic acid and its role in uremic bleeding.

Authors:  H I Horowitz; I M Stein; B D Cohen; J G White
Journal:  Am J Med       Date:  1970-09       Impact factor: 4.965

5.  Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs.

Authors:  J R Vane
Journal:  Nat New Biol       Date:  1971-06-23

6.  The cutaneous amyloidoses. II. Systemic forms.

Authors:  M H Brownstein; E B Helwig
Journal:  Arch Dermatol       Date:  1970-07

7.  The standardized normal Ivy bleeding time and its prolongation by aspirin.

Authors:  C H Mielke; M M Kaneshiro; I A Maher; J M Weiner; S I Rapaport
Journal:  Blood       Date:  1969-08       Impact factor: 22.113

8.  Fibrinogen and platelets in the primary arrest of bleeding. Studies in two patients with congenital afibrinogenemia.

Authors:  H J Weiss; J Rogers
Journal:  N Engl J Med       Date:  1971-08-12       Impact factor: 91.245

9.  Hemostatic defects in dysproteinemias.

Authors:  H A Perkins; M R MacKenzie; H H Fudenberg
Journal:  Blood       Date:  1970-05       Impact factor: 22.113

10.  The effect of clinical dextran on platelet aggregation, adhesion, and ADP release in man: in vivo and in vitro studies.

Authors:  H J Weiss
Journal:  J Lab Clin Med       Date:  1967-01
View more
  2 in total

1.  Platelet dysfunction and migraines.

Authors:  L Kudrow
Journal:  West J Med       Date:  1981-05

2.  The effect of oral phenylbutazone on whole blood platelet aggregation in the dog.

Authors:  M L Jackson; G P Searcy; D W Olexson
Journal:  Can J Comp Med       Date:  1985-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.